Key facts
- Adam Hansard has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $3,950,433.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Adam Hansard
- Location
- New York, NY
- Summary
- The estimated net worth of Adam Hansard is at least $3,950,433 dollars as of 18 Mar 2024. Adam Hansard is the Chief Commercial Officer of Applied Therapeutics, Inc. and owns shares of Applied Therapeutics, Inc. stock worth about $3.95M.
- Signature
- /s/ Shoshana Shendelman, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Adam Hansard and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Change
- Largest disclosed position: Applied Therapeutics, Inc. ($3,950,433).
- Past-year value change for that position: .
Research use
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Adam Hansard
APLT
Forms 3/4/5
Applied Therapeutics, Inc.
- Relationship
- Chief Commercial Officer
- Holdings value
- $3,950,433
- Past year net change
- Change %
- Report period
- 14 Mar 2024
Insider Transactions Reported by Adam Hansard:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.